• No results found

[PDF] Top 20 Poly(hydroxy acid) Nanoparticles for the Encapsulation and Controlled Release of Doxorubicin

Has 10000 "Poly(hydroxy acid) Nanoparticles for the Encapsulation and Controlled Release of Doxorubicin" found on our website. Below are the top 20 most common "Poly(hydroxy acid) Nanoparticles for the Encapsulation and Controlled Release of Doxorubicin".

Poly(hydroxy acid) Nanoparticles for the Encapsulation and Controlled Release of Doxorubicin

Poly(hydroxy acid) Nanoparticles for the Encapsulation and Controlled Release of Doxorubicin

... free doxorubicin revealed further that the encapsulated drug is released in a controlled and sustained manner from both sets of ...‘burst’ release profile at both pH ...free doxorubicin had ... See full document

18

Poly(hydroxy acid) Nanoparticles for the Encapsulation and Controlled Release of Doxorubicin

Poly(hydroxy acid) Nanoparticles for the Encapsulation and Controlled Release of Doxorubicin

... solution was added dropwise to the cooled reaction medium, over a period of 30 minutes. The reaction medium was maintained at 0 °C for 2 hours, and then at room temperature for 18 hours. Further steps were carried out as ... See full document

14

Exploiting Poly(α-Hydroxy Acids) for the Acid-Mediated Release of Doxorubicin and Reversible Inside−Out Nanoparticle Self-Assembly

Exploiting Poly(α-Hydroxy Acids) for the Acid-Mediated Release of Doxorubicin and Reversible Inside−Out Nanoparticle Self-Assembly

... Biodegradable poly(α-hydroxy acid) copolyesters consisting of benzyl-protected glutamic acid and carboxybenzyl- protected lysine derived blocks possess the capability to self-assemble to form ... See full document

9

Polyaspartic acid-anchored  mesoporous silica nanoparticles for pH-responsive doxorubicin release

Polyaspartic acid-anchored mesoporous silica nanoparticles for pH-responsive doxorubicin release

... drug release of DOX@P-MSNs dispersed in PBS solutions of different pH conditions (pH values mimicking normal physiological conditions, tumor microenvironment and cellular endosomal/lysosomal compartments) was ... See full document

12

Pectin-Chitosan Polyelectrolyte Complex Nanoparticles for Encapsulation and Controlled Release of Nisin

Pectin-Chitosan Polyelectrolyte Complex Nanoparticles for Encapsulation and Controlled Release of Nisin

... acid which can be partially methyl esterified. According to degree of esterification (DE), pectins are divided into low methoxyl pectin (LPE, DE < 50%) and high methoxyl pectin (HPE, DE > 50%) [24, 25]. ... See full document

7

Dextran-&lt;em&gt;b&lt;/em&gt;-poly(&lt;em&gt;L&lt;/em&gt;-histidine) copolymer nanoparticles for pH-responsive drug delivery to tumor cells

Dextran-<em>b</em>-poly(<em>L</em>-histidine) copolymer nanoparticles for pH-responsive drug delivery to tumor cells

... drug release from the nanoparticles. As shown in Table 2, doxorubicin was encapsulated into the nanoparticles with higher than 60% loading ...DexPHS-2 nanoparticles were smaller than ... See full document

11

Exploiting Poly(α-Hydroxy Acids) for the Acid-Mediated Release of Doxorubicin and Reversible Inside−Out Nanoparticle Self-Assembly

Exploiting Poly(α-Hydroxy Acids) for the Acid-Mediated Release of Doxorubicin and Reversible Inside−Out Nanoparticle Self-Assembly

... With regard to solution-state samples (e.g., nanoparticles), a micropipette was used to extract approximately 20 µL of the sample from the parent suspension. The extracted sample was placed onto an SEM glass cover ... See full document

14

Encapsulation and Controlled Release of rHu-Erythropoietin from Chitosan Biopolymer Nanoparticles

Encapsulation and Controlled Release of rHu-Erythropoietin from Chitosan Biopolymer Nanoparticles

... and nanoparticles for encapsulation and controlled release of therapeutic agents ...for nanoparticles formation ...and nanoparticles has garnered much attention because the ... See full document

144

Co-encapsulation of magnetic Fe&lt;sub&gt;3&lt;/sub&gt;O&lt;sub&gt;4&lt;/sub&gt; nanoparticles and doxorubicin into biodegradable PLGA nanocarriers for intratumoral drug delivery

Co-encapsulation of magnetic Fe<sub>3</sub>O<sub>4</sub> nanoparticles and doxorubicin into biodegradable PLGA nanocarriers for intratumoral drug delivery

... [poly(D,L-lactic-co-glycolic acid)] was used to prepare the ...vitro release profiles of DOX from DOX-MNPs were examined in both acidic and neutral ...of nanoparticles by the LLC cells was ... See full document

12

Poly(Ester Amide) and Poly(Ethyl Glyoxylate) Nanoparticles for Controlled Drug Release

Poly(Ester Amide) and Poly(Ethyl Glyoxylate) Nanoparticles for Controlled Drug Release

... polymeric nanoparticles (NPs) having improved drug release properties for drug ...delivery. Poly(ester amide)s (PEAs) are promising biodegradable ...L-aspartic acid and rhodamine B were ... See full document

135

Encapsulation Efficiency and Release of Green Tea Polyphenols from Poly (Lactic Acid) - Poly (Ethylene Glycol) Nanoparticles are Controlled by the ratio of Poly (Lactic Acid) / Poly (Ethylene Glycol)

Encapsulation Efficiency and Release of Green Tea Polyphenols from Poly (Lactic Acid) - Poly (Ethylene Glycol) Nanoparticles are Controlled by the ratio of Poly (Lactic Acid) / Poly (Ethylene Glycol)

... in nanoparticles prepared from different ratios of poly (lactic acid) (PLA)/poly (ethylene glycol) ...loaded nanoparticles were synthesized and ...GTP release was carried out ... See full document

9

ENCAPSULATION OF IBUPROFEN INTO SOLID LIPID NANOPARTICLES FOR CONTROLLED AND SUSTAINED RELEASE USING EMULSIFICATION SOLVENT EVAPORATION TECHNIQUE

ENCAPSULATION OF IBUPROFEN INTO SOLID LIPID NANOPARTICLES FOR CONTROLLED AND SUSTAINED RELEASE USING EMULSIFICATION SOLVENT EVAPORATION TECHNIQUE

... that nanoparticles can be prepared as effective tools for drug ...The nanoparticles can overcome the limitation of drug delivery by penetrating the physiological barrier to deliver the drug to the site of ... See full document

8

Antibacterial activity and biological performance of a novel antibacterial coating containing a halogenated furanone compound loaded poly(L-lactic acid) nanoparticles on microarc-oxidized titanium

Antibacterial activity and biological performance of a novel antibacterial coating containing a halogenated furanone compound loaded poly(L-lactic acid) nanoparticles on microarc-oxidized titanium

... coating (Figure 1F). At the first day, the inhibition zone was biggest, due to the initial burst release of small amounts of BBF. From day 2 to day 45, the released BBF maintained at a steady amount with just a ... See full document

11

Synthesis of Chitosan Nanoparticles for Controlled Release of Amiodarone

Synthesis of Chitosan Nanoparticles for Controlled Release of Amiodarone

... loaded nanoparticles is ...chitosan nanoparticles quite successfully. At the same time, AMD in nanoparticles lost its crystallinity, which is a less soluble form to its amorphous ... See full document

8

Targeting thyroid cancer with acid-triggered release of doxorubicin from silicon dioxide nanoparticles

Targeting thyroid cancer with acid-triggered release of doxorubicin from silicon dioxide nanoparticles

... dioxide nanoparticles with thyroid–stimulating-hormone receptor- targeting ligand that can specifically target the thyroid ...cancer. Doxorubicin nanoparticles can be triggered by acid to ... See full document

11

Stepwise encapsulation and controlled two-stage release system for cis-Diamminediiodoplatinum

Stepwise encapsulation and controlled two-stage release system for cis-Diamminediiodoplatinum

... a release medium in a dissolution cup. In vitro drug release was studied on five nanoparticles obtained at different PEG-4000/SL weight ...two release solutions (named “A” and “B”) with the ... See full document

8

&lt;p&gt;Enhanced Chemotherapeutic Efficacy of PLGA-Encapsulated Epigallocatechin Gallate (EGCG) Against Human Lung Cancer&lt;/p&gt;

<p>Enhanced Chemotherapeutic Efficacy of PLGA-Encapsulated Epigallocatechin Gallate (EGCG) Against Human Lung Cancer</p>

... PLGA nanoparticles were prepared using the oil-in-water emulsion solvent evaporation technique PLGA-NPs loaded EGCG. Brie fl y, for the preparation of EGCG-encapsulated PLGA-NPs, the ratio between the volume of ... See full document

13

The intratumoral administration of ferucarbotran conjugated with doxorubicin improved therapeutic effect by magnetic hyperthermia combined with pharmacotherapy in a hepatocellular carcinoma model

The intratumoral administration of ferucarbotran conjugated with doxorubicin improved therapeutic effect by magnetic hyperthermia combined with pharmacotherapy in a hepatocellular carcinoma model

... In this study, we performed BLI for in vivo monitoring of the therapeutic effect. BLI requires a reporter construct produce luciferase, an enzyme that provides imaging con- trast by light emission resulting from ... See full document

11

Formulation and Evaluation of Moxifloxacin Loaded Alginate Chitosan Nanoparticles

Formulation and Evaluation of Moxifloxacin Loaded Alginate Chitosan Nanoparticles

... al. Calcium chloride (18 mM) was added dropwise for 60 min under magnetic stirring into beaker containing sodium alginate solution (0.05%) to provide alginate pregel. The different concentration of drug (25 to 100 mg) is ... See full document

5

Encapsulation of exemestane in polycaprolactone nanoparticles: optimization, characterization, and release kinetics

Encapsulation of exemestane in polycaprolactone nanoparticles: optimization, characterization, and release kinetics

... succinic acid to PCL by ring opening ...sustained release and followed Fickian diffusion based release ...sustained release delivery system of exe would reduce the side effects associated with ... See full document

15

Show all 10000 documents...